Cargando…

1649. Characterizing Factors Associated with Pediatric Latent Tuberculosis Infection in an Urban Health System to Improve Screening Practices

BACKGROUND: The epidemiology and risk factors informing current American Academy of Pediatrics (AAP) guidelines on screening for pediatric latent tuberculosis infection (LTBI) have evolved over the past decade. To improve pediatric LTBI screening efficiency, we sought to reevaluate characteristics a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoekstra, Nadia E, Anderson, Mark, Gaensbauer, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778107/ http://dx.doi.org/10.1093/ofid/ofaa439.1827

Ejemplares similares

P1649: STUDIES OF COMPLEX PRODUCTS BASED ON HEPARINS OF ANIMAL AND PLANT ORIGIN
por: Lyapina, Margarita, et al.
Publicado: (2023)

1649 Acquisition of Clostridium difficile Associated with Potentially Contaminated Inpatient Rooms
por: Williams, Catherine, et al.
Publicado: (2014)

Frontispiece of Manual of Anatomy by Jean Riolan (1649)
Publicado: (1922)

1643. A scoping review of pediatric latent tuberculosis care cascades: Initial steps are lacking
por: Campbell, Jeffrey, et al.
Publicado: (2020)

1649. Tracking and reporting antibiotic use: Rising antibiotic prescriptions for URI illness in children during the COVID-19 pandemic.
por: Clemons, Emily, et al.
Publicado: (2023)

1649. That’s Not Cricket! Outbreak of Legionella pneumophila (L. pneumophila) in a Community Cricket Club in the UK, 2018: Challenges in Legionella Control in This Setting
por: Wright, Natalie, et al.
Publicado: (2019)

345. Early Oral Therapy for Streptococcus anginosus Purulent Brain Infections: A Single Center Experience
por: Dodson, Daniel S, et al.
Publicado: (2020)

1393. Loss to Follow-up Rate in the Treatment of Latent Tuberculosis by Region of Origin
por: Yoshii, Hikari, et al.
Publicado: (2021)

Potential Antiaging Effects of DLBS1649, a Centella asiatica Bioactive Extract
por: Karsono, Agung H, et al.
Publicado: (2021)

1874. Prior Screening for Latent Tuberculosis among Patients Diagnosed with Active Tuberculosis: Missed Opportunities?
por: Garba, Saadiq, et al.
Publicado: (2023)

1376. Physician Practice Patterns for Screening and Treatment of Latent Tuberculosis Infection in the South Asian Population in Central New Jersey
por: Gulati, Nupur, et al.
Publicado: (2019)

1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy
por: Malek, Alexandre, et al.
Publicado: (2021)

752. Geographic Analysis of Latent Tuberculosis Screening: A Health System Approach
por: Bonnewell, John, et al.
Publicado: (2018)

1059. Evaluating Hepatitis C Screening Rates and Successful Interventions at an Outpatient Medicine/Pediatrics Practice
por: Abreu, Carina, et al.
Publicado: (2020)

1406. Hepatitis B and C Prevalence in Patients with Active and Latent Tuberculosis in an Ethnically Diverse Area of London, UK
por: Duret, Amedine, et al.
Publicado: (2021)

Improving screening and management of latent tuberculosis infection: development and evaluation of latent tuberculosis infection primary care model
por: Kunin, Marina, et al.
Publicado: (2022)

1407. The Latent Tuberculosis Infection Cascade of Care during the COVID-19 Pandemic Response in a Mid-Sized US City
por: Stantliff, Trevor M, et al.
Publicado: (2021)

Epidemiology and Transmission Dynamics of COVID-19 in an Urban Pediatric US Population
por: Sebastian, Thresia, et al.
Publicado: (2022)

753. Screening for Latent Mycobacterium tuberculosis Infection (LTBI): A Clinical Conundrum of Public Health Concern
por: Bricker, Lauren, et al.
Publicado: (2018)

1391. Latent Tuberculosis Screening Cascade in Liver Transplant Candidates: A Single, Transplant Center Experience
por: Medvedeva, Natalia, et al.
Publicado: (2019)

1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020)

Quantiferon-TB Gold test in screening for latent tuberculosis before and during antitumour necrosis factor treatment
por: Vencovský, J, et al.
Publicado: (2007)

473. Clinical Outcomes of a Pediatric COVID Monoclonal Antibody Program based at an Urban Academic Center
por: Lee, Philip J, et al.
Publicado: (2021)

1347. Improved Antibiotic Prescribing Practices for Respiratory Infections Through Use of Computerized Order Sets and Educational Sessions in Pediatric Clinics
por: Zahlanie, Yorgo, et al.
Publicado: (2020)

755. Clinical Adherence to Latent Tuberculosis Screening Recommendations in Adults with Inflammatory Bowel Disease (IBD) Prior to Biologic Therapy
por: Mponponsuo, Kwadwo, et al.
Publicado: (2018)

Risk of latent tuberculosis in at-risk children with rheumatic diseases
por: Lim, SC, et al.
Publicado: (2011)

796. Treatment of Latent Tuberculosis Infection in a Refugee Population
por: Herchline, Thomas, et al.
Publicado: (2018)

Screening for latent tuberculosis: the way forward for tuberculosis elimination
por: Petersen, Eskild, et al.
Publicado: (2022)

672. The Pediatric Endotracheal Aspirate Culture Survey (Petacs): Examining Practice Variation Across Pediatric Microbiology Laboratories in the United States
por: Prinzi, Andrea, et al.
Publicado: (2020)

1869. Knowledge about and Perceptions of Latent Tuberculosis Infection (LTBI) among Physicians and Advanced Practice Providers at Tufts Medical Center
por: Boomsma, Cassidy, et al.
Publicado: (2023)

1439. Latent tuberculosis infection treatment location and association with care completion
por: Campbell, Jeffrey, et al.
Publicado: (2022)

336. Developing a Protein Signature of Early Latent Tuberculosis Infection.
por: Bark, Charles, et al.
Publicado: (2022)

1901. High Prevalence of Latent Tuberculosis Infection in a Malaysian Prison
por: Zhang, Lu, et al.
Publicado: (2023)

646. Increasing Use of Interferon-Gamma Release Assay to Test for Pediatric Tuberculosis in a Low-Burden Setting
por: Campbell, Jeffrey, et al.
Publicado: (2021)

1661 Travel-Associated Infectious Disease Surveillance Using the Pediatric Health Information System (PHIS) Database
por: Olson, Daniel, et al.
Publicado: (2014)

1391. Enhanced Education and Administration of Influenza Vaccine in a Pediatric Subspecialty Practice
por: McCarthy, Carol A, et al.
Publicado: (2020)

604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases
por: Mohandas, Sindhu, et al.
Publicado: (2021)

1893. Mathematical modeling the impact of the age-dependent latent tuberculosis treatment on active tuberculosis in South Korea
por: Seong, Hye, et al.
Publicado: (2023)

1025. Integrating buprenorphine into an urban HIV primary care practice: Outcomes on viral load suppression and opioid use
por: Fabricant, Scott, et al.
Publicado: (2020)

795. Review of Treatment of Latent Tuberculosis Infection at VA Portland Healthcare System
por: Xu, Teena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v3emlitrkppg1b47quq2b36g1t